13D/13G Filings - Fairmount Funds Management LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-09-21
4:32 pm
Purchase
2023-09-1113DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC1,873,833
12.700%
1,873,833increase
(New Position)
Filing
History
2023-08-10
4:15 pm
Purchase
2023-08-0213GKiniksa Pharmaceuticals, Ltd.
KNSA
Fairmount Funds Management LLC2,143,052
6.100%
2,143,052increase
(New Position)
Filing
History
2023-07-21
4:31 pm
Purchase
2023-07-1313DApogee Therapeutics, Inc.
APGE
Fairmount Funds Management LLC3,906,202
9.990%
3,906,202increase
(New Position)
Filing
History
2023-07-07
4:00 pm
Purchase
2023-06-2813GAxsome Therapeutics, Inc.
AXSM
Fairmount Funds Management LLC2,344,980
5.000%
333,333increase
(+16.57%)
Filing
History
2023-06-30
5:24 pm
Purchase
2023-06-2213DAeglea BioTherapeutics, Inc.
AGLE
Fairmount Funds Management LLC783,600
19.990%
783,600increase
(New Position)
Filing
History
2023-06-13
4:06 pm
Purchase
2023-06-0913DCogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC19,962,564
19.990%
4,732,091increase
(+31.07%)
Filing
History
2023-04-27
10:00 am
Purchase
2023-04-1813GEnliven Therapeutics, Inc.
ELVN
Fairmount Funds Management LLC2,124,625
5.170%
2,124,625increase
(New Position)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GAnnexon, Inc.
ANNX
Fairmount Funds Management LLC3,681,456
7.700%
1,112,056increase
(+43.28%)
Filing
History
2023-02-14
3:45 pm
Sale
2022-12-3113GAxsome Therapeutics, Inc.
AXSM
Fairmount Funds Management LLC2,011,647
4.600%
-155,000decrease
(-7.15%)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Fairmount Funds Management LLC1,901,397
6.900%
989,661increase
(+108.55%)
Filing
History
2023-02-14
3:45 pm
Sale
2022-12-3113GOlema Pharmaceuticals, Inc.
OLMA
Fairmount Funds Management LLC0
0.000%
-2,107,873decrease
(Position Closed)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GNuvalent, Inc.
NUVL
Fairmount Funds Management LLC2,788,981
5.470%
183,857increase
(+7.06%)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GTerns Pharmaceuticals, Inc.
TERN
Fairmount Funds Management LLC5,269,287
9.900%
3,219,287increase
(+157.04%)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GTrevi Therapeutics, Inc.
TRVI
Fairmount Funds Management LLC6,018,465
9.900%
2,258,955increase
(+60.09%)
Filing
History
2022-11-09
10:02 am
Purchase
2022-11-0313GNuvalent, Inc.
NUVL
Fairmount Funds Management LLC2,605,124
5.130%
2,605,124increase
(New Position)
Filing
History
2022-10-25
9:09 pm
Purchase
2022-09-1613GAxsome Therapeutics, Inc.
AXSM
Fairmount Funds Management LLC2,166,647
5.400%
2,166,647increase
(New Position)
Filing
History
2022-08-25
09:32 am
Purchase
2022-08-1613GTerns Pharmaceuticals, Inc.
TERN
Fairmount Funds Management LLC2,050,000
5.450%
2,050,000increase
(New Position)
Filing
History
2022-08-19
4:34 pm
Purchase
2022-08-1713DViridian Therapeutics, Inc.
VRDN
Fairmount Funds Management LLC9,192,814
19.990%
5,732,463increase
(+165.66%)
Filing
History
2022-06-21
10:04 am
Purchase
2022-06-1613DCogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC15,230,473
19.990%
15,230,473increase
(New Position)
Filing
History
2022-04-21
10:00 am
Purchase
2022-04-1113GTrevi Therapeutics, Inc.
TRVI
Fairmount Funds Management LLC3,759,510
9.900%
3,759,510increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, Next